CTRI/2017/02/007831
Recruiting
Phase 4
Evaluating the clinical and health-economic effectiveness of a novel device for faecal management in bed-ridden patients with little to no bowel control. - NI
Consure Medical Private Limited0 sites70 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Consure Medical Private Limited
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and female patients, more than 18 years of age who have liquid to semi\-formed stool
- •Non\-ambulatory, hospitalized patients
- •History of passage of at least 1 stool in past 24 hours
- •Patient or a legal representative of the patient gives written consent for the study
Exclusion Criteria
- •Patients enrolled in another clinical study or trial will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000036455Department of Radiation Oncology, Gunma University Graduate School of Medicine54
Active, not recruiting
Phase 1
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity following strokeEUCTR2004-002427-40-GBewcastle Upon Tyne Hospitals NHS Foundation Trust332
Completed
Not Applicable
What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?pper limb spasticity due to strokeCirculatory SystemStrokeISRCTN78533119The Newcastle Upon Tyne Hospitals NHS Foundation Trust (UK)390
Active, not recruiting
Phase 1
IMPACT ON THE CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF THE ANTIMICROBIAL THERAPEUTIC MONITORING PROGRAM IN CRITICAL PATIENTS- Respiratory infections- Urogenital infections - Abdominal infectionsMedDRA version: 20.1Level: LLTClassification code 10056570Term: Intra-abdominal infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10038700Term: Respiratory infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10065583Term: Urogenital infection bacterialSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2019-004947-65-ESSantiago Grau Cerrato230
Completed
Not Applicable
Health Economic Evaluation of costs and benefits of a computer based program called Deprexis used for insured persons of the DAK (statutory health insurance) suffering from depressioF32.0F32.1Mild depressive episodeModerate depressive episodeDRKS00003564D A K - GesundheitUnternehmen LebenVorstandsreferat Versorgungsforschung (0010 30)3,832